cis-trismethoxy Resveratrol

CAS No. 94608-23-8

cis-trismethoxy Resveratrol( (Z)-3,5,4'-Trimethoxystilbene )

Catalog No. M27995 CAS No. 94608-23-8

cis-trismethoxy Resveratrol inhibits tubulin polymerization (IC50 = 4 μM) and has anti-mitotic effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 49 Get Quote
25MG 71 Get Quote
50MG 99 Get Quote
100MG 142 Get Quote
500MG 351 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    cis-trismethoxy Resveratrol
  • Note
    Research use only, not for human use.
  • Brief Description
    cis-trismethoxy Resveratrol inhibits tubulin polymerization (IC50 = 4 μM) and has anti-mitotic effects.
  • Description
    cis-trismethoxy Resveratrol inhibits tubulin polymerization (IC50 = 4 μM) and has anti-mitotic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    (Z)-3,5,4'-Trimethoxystilbene
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Microtubule/Tubulin
  • Recptor
    G-quadruplex
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    94608-23-8
  • Formula Weight
    270.32
  • Molecular Formula
    C17H18O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O(C1=CC=C(C=C1)C=CC=2C=C(OC)C=C(OC)C2)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Marialuisa Micco, et al. Structure-based design and evaluation of naphthalene diimide G-quadruplex ligands as telomere targeting agents in pancreatic cancer cells. J Med Chem
molnova catalog
related products
  • VERU-111

    VERU-111 (VERU111) is a novel potent colchicine binding site inhibitor (CBSI) in tubulin with potential anticancer activities.

  • DM1-SMe

    DM1-SMe is a potent inhibitor of maytansinoid microtubular. DM1-SMe is about 3 to 10-fold more potent than the parent drug Maytansine, with IC50s of 0.003 to 0.01 nM for DM1-SMe in a panel of human tumor cell lines.

  • VERU-111 analogue 13...

    VERU-111 analogue 13f is a novel potent colchicine binding site inhibitor (CBSI) in tubulin with potential anticancer activities.